Navigation Links
Groundbreaking cancer research receives massive funding boost
Date:1/11/2012

Research into a ground-breaking treatment for bowel cancer at Queen's University Belfast has received a massive funding boost from Cancer Research UK.

Dr Sandra Van Schaeybroeck, whose research aims to identify ways to increase survival from bowel cancer, has received a prestigious 688,000 Cancer Research UK Clinical Scientist Fellowship.

The award, which is one of only four fellowships awarded to UK clinical investigators, renews Dr Schaeybroeck's current funding from the charity for another three years. Her research aims to develop new treatment strategies to improve bowel cancer patients' response to treatment and increase survival of particular groups of patients with bowel cancer.

Dr Van Schaeybroeck, from the School of Medicine, Dentistry and Biomedical Sciences at Queen's, said: "Bowel cancer affects more that 35,000 people a year in the UK. A major barrier in the treatment of bowel cancer is drug resistance with more than half of patients not responding to standard chemotherapy treatment. I'm specifically aiming to identify the molecular reasons this happens in cells with specific gene faults. My ultimate goal is to increase survival in particular groups of patients with bowel cancer.

"I'm delighted to have received the renewal of the Cancer Research UK Clinician Scientist Fellowship. It is a major recognition of my research so far and the world-class cancer research ongoing at Queen's University.

Speaking about the selection process, Professor Philip Johnson, Chair of the clinical interview panel and a world leader in cancer trials at the University of Birmingham, said: "We saw oncologists, surgeons, haematologists, public health specialists and more. It was a tough decision, but we have found five great post-doc clinicians. These are people who see clinical problems that need solving, and then do research to find solutions. They have an exciting and rewarding career ahead of them."

Dr David Scott, Cancer Research UK's Director of Science Funding, said: "The doctors receiving this funding are carrying out world-class research to develop new ways to diagnose and treat patients more effectively. We hope this funding will be an important boost to develop new approaches which we hope will ultimately increase survival from cancer."

The funding is part of a total three million pound funding pot awarded to the five UK researchers - an important investment from Cancer Research UK, with the aim of identifying the next generation of clinical research leaders in the UK.


'/>"/>

Contact: Claire O'Callaghan
c.ocallaghan@qub.ac.uk
Queen's University Belfast
Source:Eurekalert

Related medicine news :

1. Groundbreaking male infertility test could bring hope to millions
2. Brain function linked to birth size in groundbreaking new study
3. Second volume of groundbreaking Emerging Model Organisms series is released
4. Groundbreaking MS research to be presented at American Academy of Neurology Annual Meeting
5. LASIK Surgeons, Plastic Surgeons, Cosmetic Dentists and other Cash Paid Medical Specialists Brought Together for Groundbreaking Webinar Series
6. Groundbreaking research to find vaccine for hepatitis C
7. Groundbreaking Study Using Ultrasound for the Treatment of Intracerebral and Intraventricular Hemorrhage Stroke Shows Promise
8. $250,000 Grant Awarded for Groundbreaking Ligament and Tendon Repair Research
9. $250,000 grant awarded for groundbreaking ligament and tendon repair research
10. Texas-based consortium announces groundbreaking vaccine research program
11. Groundbreaking Principal and Contributor on Dr. Oz Show Releases His Latest Book on How We Can Influence the Lives of Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Chicago, Illinois (PRWEB) , ... March 29, 2017 ... ... Visio Stencils Device Library for documenting and diagramming network and data center assets ... , NetZoom subscribers can request new equipment shapes for free and download ...
(Date:3/29/2017)... ... , ... Immunotherapy has emerged as one of the most promising options for ... the next revolution in our fight against this complex disease. One of the most ... inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry ...
(Date:3/29/2017)... ... ... AvePoint , the Microsoft Cloud expert, is pleased to announce the ... the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ceremony ... Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more than ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies ... directly address the resolution to globally reduce the harmful use of alcohol set ... FDA and TTB approved ingredients that when infused into alcohol, renders the alcohol ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 On March 28, the ... treat adult patients with relapsing forms of multiple sclerosis ... the first drug approved by the FDA for PPMS. ... care professional.  "Multiple sclerosis can have ... Billy Dunn , M.D., director of the Division of ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... Data published in a research report by Grand View Research, ... of USD 55.8 billion by 2025. The projection takes into consideration the ... and a more open approach towards cannabis products around the world. In ... , North Dakota , Ohio , ...
(Date:3/29/2017)... , March 29, 2017 FinancialBuzz.com News ... The U.S. ... According to a new report published by New Frontier Data, the ... The accelerating pace of cannabis legalization in the United ... cannabis, are considered to be a major factor that drives growth ...
Breaking Medicine Technology: